RxDoctor Payments Data

Michael Mendelsohn

Internal Medicine · Boston, MANPI 1851435549

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,550,315 of the $1,552,547 with a category attached, or 99.9%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 98.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $456,000 and has fallen 86.8% since, to $60,143 in 2024. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,552,547in general payments, 2019–2025

Across 96 payments — averaging $16,172 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$1.5M
  • Ironwood Pharmaceuticals, Inc$31K
  • Takeda Pharmaceutical Company, Limited$22
$2,246,242in research payments, 2019–2025

Across 1 payment — averaging $2,246,242 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceutical Company, Limited$2.2M

What the payments were for

  • Consulting fees$1,550,315100%
  • Travel & lodging$2,0890%
  • Food & beverage$1430%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,552,547 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts →

Other internal medicine in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →